![John Henderson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Henderson
Vorsitzender bei
CYTOKINETICS, INCORPORATED
Vermögen: 6 Mio $ am 31.05.2026
Profil
John Tannahill Henderson currently works at Cytokinetics, Inc., as Chairman from 2022.
Dr. Henderson also formerly worked at Asmacure Ltée, as Chairman, Myriad Genetics, Inc., as Independent Director in 2020, Inveresk Research Group, Inc., as Non-Executive Director, Myrexis, Inc., as Independent Director from 2011 to 2013, Pfizer Pharmaceuticals, Inc., as Vice President, Futurepharm LLC, as President, NeuroVia, Inc., as Chief Development Officer, and Pfizer Inc., as VP-Europe, US & International Pharmaceuticals.
Dr. Henderson received his undergraduate degree and doctorate degree from The University of Edinburgh.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 27.05.2026 | 78.171 ( 0,06 % ) | 6 Mio $ | 31.05.2026 |
Aktive Positionen von John Henderson
| Unternehmen | Position | Beginn |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Vorsitzender | 08.04.2022 |
Ehemalige bekannte Positionen von John Henderson
| Unternehmen | Position | Ende |
|---|---|---|
| MYRIAD GENETICS, INC. | Vorsitzender | 23.03.2020 |
NeuroVia, Inc.
 NeuroVia, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule therapeutics for the treatment of neurologic disorders | Corporate Officer/Principal | 01.10.2018 |
| MYREXIS, INC. | Direktor/Vorstandsmitglied | 01.01.2013 |
Pfizer Pharmaceuticals, Inc.
 Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01.12.2000 |
| PFIZER INC. | Corporate Officer/Principal | 01.12.2000 |
Ausbildung von John Henderson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
48
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Myriad Genetics, Inc.
 Myriad Genetics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and predictive medicine products | Health Technology |
Inveresk Research Group, Inc.
 Inveresk Research Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development services | Commercial Services |
Cytokinetics, Inc.
 Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
Myrexis, Inc.
 Myrexis, Inc. Financial ConglomeratesFinance Engages in identifying, evaluating and making financial investments in life sciences assets | Finance |
The University of Edinburgh
 The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Asmacure Ltée
 Asmacure Ltée Pharmaceuticals: MajorHealth Technology Develops novel, proprietary compounds that target cholinergic receptors for the treatment of inflammation, notably pulmonary airway diseases | Health Technology |
Pfizer Pharmaceuticals, Inc.
Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Futurepharm LLC | |
NeuroVia, Inc.
NeuroVia, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule therapeutics for the treatment of neurologic disorders | Health Technology |
